Poor Trial Results May Prompt Maker to Pull ALS Drug Relyvrio From Market
MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a...
What's Your Reaction?